Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Johnson & Johnson Expands U.S. Footprint with more than $1 Billion Investment in Next Generation Cell Therapy Manufacturing Facility in Pennsylvania
Johnson & Johnson announced a more than $1 billion investment in a new cell therapy manufacturing facility in Montgomery County, Pennsylvania. This investment is part of the company’s $55 billion U.S. investment plan and aims to expand its manufacturing capacity for advanced medicines, creating over 500 biomanufacturing jobs and 4,000 construction jobs. The facility will utilize cutting-edge cell therapy technologies to support Johnson & Johnson’s portfolio in cancer, immune-mediated, and neurological diseases.